Publication: 2460

Publication: 2460

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Support Care Cancer vol 26 (2) 643-650

Year:: 2018
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 7

Parents:: 2098 2223
Children:: None

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:: Health Outcomes

Pharmas:
Grants:: U10CA035101, U10CA035103, U10CA035113, U10CA035119, U10CA035195, U10CA035267, U10CA035269, U10CA035415, U10CA035431, U10CA035448, U10CA037404, U10CA037417, U10CA052352, U10CA063848, U10CA063849, U10CA180790, UG1CA189863, UG1CA189971.

Corr. Author:
Authors:: Debra L. Barton Jeff A. Sloan Lynne T. Shuster Paula Gill Patricia Griffin Kathleen Flynn Shelby A. Terstriep Fauzia N. Rana Travis Dockter Pamela J. Atherton Michaela Tsai Keren Sturtz Jacqueline M. Lafky Mike Riepl Jacqueline Thielen Charles L. Loprinzi

Networks:: CO012, LAPS-MN026, MCRC, MONTANA, PCRC, SANFORD, UPSTATE

Study: NCCTG-N10C1
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: